Sign in

You're signed outSign in or to get full access.

TP

TEVA PHARMACEUTICAL INDUSTRIES (TEVA)·Earnings Reports

Teva Q4 2025 earnings results — EPS beat by 50%, revenue beat by 8.6%

Q4 2025

View earnings summary and analysis

Q3 2025

View earnings summary and analysis

Q2 2025

View earnings summary and analysis

Q1 2025

View earnings summary and analysis

Q4 2024

View earnings summary and analysis

Analyst Coverage

Research analysts covering TEVA PHARMACEUTICAL INDUSTRIES.

Recent News about TEVA PHARMACEUTICAL INDUSTRIES

Teva's Duvakitug Delivers 58% Remission in IBD Maintenance Trial, Stock Jumps 4% After Hours
Corporate

Teva's Duvakitug Delivers 58% Remission in IBD Maintenance Trial, Stock Jumps 4% After Hours

Feb 17
Royalty Pharma Bets $500M on Teva's Vitiligo Antibody, Targeting Market With Only One Approved Drug
Deals & Capital Markets

Royalty Pharma Bets $500M on Teva's Vitiligo Antibody, Targeting Market With Only One Approved Drug

Jan 12
View all news